Hospital y CRS El Pino

Santiago 8053095

0 studies enrolling now · 2 studies all time

What they study most

Atrial Fibrillation, Cardiovascular Disease, Stroke

Studies at this site

• GLORIA-AF Registry Program - Second and Third Phases — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early